The short version of reconstitution fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-07 and is reviewed periodically as new material appears.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
Detection in biological samples relies on mass spectrometry, typically liquid chromatography coupled to tandem mass spectrometry after peptide extraction and enrichment. Intact peptides can also be confirmed by high-resolution mass measurement together with fragmentation data. Detection windows in urine are short because the peptide is degraded by proteases and cleared quickly, and concentrations are low. Many jurisdictions treat the compound as a prohibited substance in sport, grouped with peptide hormones and related factors, while it is not an approved therapeutic product. Identity and purity statements therefore rest on certificates of analysis, ideally issued by an independent laboratory.
Material is normally supplied as a lyophilised powder in a sealed vial. The powder is hygroscopic, so exposure to humid air leads to water uptake, caking and gradual loss of the fluffy texture that indicates a good freeze-dry. Vials are best kept sealed with desiccant, protected from light and stored cold. Letting a cold vial warm to room temperature before opening reduces condensation on the contents. Purity is normally reported from a chromatographic run, and that figure applies to the batch as tested rather than to the vial after repeated opening.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
EC 7.1.1 Hydron translocation or charge separation linked to oxidoreductase reactions EC 7.1.2 Hydron translocation linked to the hydrolysis of a nucleoside triphosphate EC 7.1.3 Hydron translocation linked to the hydrolysis of diphosphate An important translocase contained in this group is ATP synthase, also known as EC 7.1.2.2.
Outrageous. It exacerbates inequality and social division—one of the main problems of the USA. It deprives vulnerable groups of access to health care. Life expectancy is already declining, and the health differences between rich and poor are enormous. This law exacerbates this. The nonpartisan Tax Foundation had mixed opinions of the bill, saying it made "some smart cuts", in particular praising the extension of the Tax Cuts and Jobs Act of 2017 which it argued would provide stability for households. It also expressed support for its impacts on counting international business income. It criticized the political nature of the bill, calling it filled with carve-outs and political gimmicks that increased the complexity of the tax code. It also criticized the bill's non-equal application of taxation on citizens. The Economist described the bill's policies and passage as an example of "America's creeping dysfunction", criticizing its impact on increasing the deficit and describing its tax cuts as "gimmicks". It also criticized Trump's handling of the economy more broadly, saying the bill "illustrates the long-term damage Mr Trump is doing to the foundations of America's economy" and describing its passage as exacerbating the effects of Trump's attacks on the Federal Reserve, defunding of scientific research, high tariff policy, and erosion to the rule of law. It described these cumulative effects as threatening America's economic stability and making it a riskier place to invest.
=== Potential data collection by the Chinese government === Concerns have been raised about the potential control and influence of the Chinese government over TikTok's owner, ByteDance, in particular the extraterritorial implications of China's 2017 National Intelligence Law. An article in the law insists that all organizations and citizens shall "support, assist and cooperate with national intelligence efforts." Analysts differ in their assessments of the data collection risks. Jim Lewis of the Center for Strategic and International Studies said TikTok would have no right to appeal requests for data made by the Chinese government. Some cybersecurity experts say individual users are not at risk. The United States has not offered any evidence of TikTok sharing such information with Chinese authorities. Keeping user data within the United States became the motivation behind TikTok's Project Texas.
=== Category:EC 1.17 (act on CH or CH2 groups) === Category:EC 1.17.1 Leucoanthocyanidin reductase EC 1.17.1.3 Xanthine dehydrogenase EC 1.17.1.4 Nicotinate dehydrogenase EC 1.17.1.5 4-hydroxy-tetrahydrodipicolinate reductase EC 1.17.1.8 Category:EC 1.17.2 Nicotinate dehydrogenase (cytochrome) EC 1.17.2.1 Category:EC 1.17.3 Xanthine oxidase EC 1.17.3.2 Category:EC 1.17.4 Ribonucleotide reductase EC 1.17.4.1 Ribonucleoside-triphosphate reductase EC 1.17.4.2 Vitamin K epoxide reductase Vitamin-K-epoxide reductase (warfarin-sensitive) EC 1.17.4.4 Vitamin-K-epoxide reductase (warfarin-insensitive) EC 1.17.4.5 RRM1 RRM2 RRM2B Category:EC 1.17.5 Caffeine dehydrogenase EC 1.17.5.2 Category:EC 1.17.7 Category:EC 1.17.99
On 8 February 2022, Aníbal Torres was appointed as Prime Minister of Peru. Torres had previously served as the Minister of Justice. The appointment of President Pedro Castillo's fourth cabinet came in the context of an attempt to resolve a political crisis.
Sources: en.wikipedia.org
Vicuña wool refers to the hair of the South American vicuña, a camelid related to llamas and alpacas. The wool has, after shahtoosh, the second smallest fiber diameter of all animal hair and is the most expensive legal wool.
{\displaystyle {\begin{aligned}&{\frac {dS}{dt}}=-{\frac {\beta IS}{N}},\\[6pt]&{\frac {dI}{dt}}={\frac {\beta IS}{N}}-\gamma I-\mu I,\\[6pt]&{\frac {dR}{dt}}=\gamma I,\\[6pt]&{\frac {dD}{dt}}=\mu I,\end{aligned}}}
=== July === 1 July: The Government's Healthy Homes standards come into effect, parental leave payments increase, Jobseeker welfare beneficiaries will need to reapply every six months, the Government's KiwiSaver contributions drop from 50 cents to 25 cents per dollar, ACC payments increase by 2.89%, and public transport fares rise nationwide. Farms will be required to keep raw milk records in order to combat the spread of mycoplasma bovis. The weight loss drug Semaglutide (Wegovy) becomes available in New Zealand. Justice Minister Paul Goldsmith and Associate Justice Minister Nicole McKee announce several tougher penalties that they claim will combat shoplifting. 2 July — The New Zealand Space Agency confirms that contact with the emissions-monitoring satellite MethaneSAT had been lost on 20 June and that recovery was unlikely. The New Zealand Government had contributed NZ$29 million to the US-based Environmental Defense Fund's MethaneSAT, which was tasked with monitoring oil and gas emissions. 3 July: Goldsmith and McKee announce longer periods and fines for trespassing. Local authorities extended the state of emergency in Nelson, Tasman and Marlborough for another seven days in response to forecast heavy rain. A severed fiber-optic cable causes mobile phone and power outages in Golden Bay, Tasman. A line fault causes power outages to 2,000 properties in the Selwyn District including Rolleston and Templeton. Torrential rain leads to flooding, landslips, sewage overflows and evacuations in parts of Taranaki including New Plymouth.
=== Column === The column is a glass or plastic cylinder packed with beads of resin and filled with buffer solution. It is normally mounted vertically with the buffer flowing downward from top to bottom. A glass frit at the bottom of the column retains the resin beads in the column while allowing the buffer and dissolved proteins to exit.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.